xCures’ technology harnesses real-time patient data and makes it accessible for scientific exploration and to improve patient options. We believe this partnership will have a crucial role in advancing ...

SAN FRANCISCO. (KFSN) -- DIPG is the second most common brain tumor in kids. The diagnosis is tough to deliver. It is almost always the same-little boys and girls are given less than two years to live ...

DENVER, Colorado -- Without almost any warning a Denver family's life was flipped upside down. Yet in the face of heartbreak and sadness, one mom is choosing strength and resolve, KMGH-TV reports.

A major milestone in open science drug discovery is marked by the advancement of M4K Pharma’s ALK2 inhibitor program into IND-enabling studies for Diffuse Intrinsic Pontine Glioma (DIPG). The ...

Kristyn Niederhaus’ arm is adorned with colorful tattoos and reminders of her daughter Brynnley. Brynnley Niederhaus fought a brave fight before dying from a rare brain tumor (DiPG) in November. Her ...